CA2611072A1 - Composes inedits et leurs utilisations - Google Patents

Composes inedits et leurs utilisations Download PDF

Info

Publication number
CA2611072A1
CA2611072A1 CA002611072A CA2611072A CA2611072A1 CA 2611072 A1 CA2611072 A1 CA 2611072A1 CA 002611072 A CA002611072 A CA 002611072A CA 2611072 A CA2611072 A CA 2611072A CA 2611072 A1 CA2611072 A1 CA 2611072A1
Authority
CA
Canada
Prior art keywords
optionally substituted
compound
6alkyl
irap
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002611072A
Other languages
English (en)
Inventor
Siew Yeen Chai
Michael William Parker
Anthony Lloyd Albiston
Frederick A. O. Mendelsohn
Keith Geoffrey Watson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Vincents Institute of Medical Research
Florey Institute of Neuroscience and Mental Health
Original Assignee
Howard Florey Institute of Experimental Physiology and Medicine
St Vincents Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Howard Florey Institute of Experimental Physiology and Medicine, St Vincents Institute of Medical Research filed Critical Howard Florey Institute of Experimental Physiology and Medicine
Priority to CA002611072A priority Critical patent/CA2611072A1/fr
Publication of CA2611072A1 publication Critical patent/CA2611072A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002611072A 2007-11-19 2007-11-19 Composes inedits et leurs utilisations Abandoned CA2611072A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002611072A CA2611072A1 (fr) 2007-11-19 2007-11-19 Composes inedits et leurs utilisations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002611072A CA2611072A1 (fr) 2007-11-19 2007-11-19 Composes inedits et leurs utilisations

Publications (1)

Publication Number Publication Date
CA2611072A1 true CA2611072A1 (fr) 2009-05-19

Family

ID=40652816

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002611072A Abandoned CA2611072A1 (fr) 2007-11-19 2007-11-19 Composes inedits et leurs utilisations

Country Status (1)

Country Link
CA (1) CA2611072A1 (fr)

Similar Documents

Publication Publication Date Title
US8377963B2 (en) Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof
Chowdhury et al. Phenotypic optimization of urea–thiophene carboxamides to yield potent, well tolerated, and orally active protective agents against aminoglycoside-induced hearing loss
Chen et al. 5-Cyano-6-oxo-1, 6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP
US8008341B2 (en) Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
ES2403340T3 (es) Inhibidores de aminopeptidasa regulada por insulina (IRAP) y usos de los mismos
TWI653226B (zh) 雜環衍生物及其用途
JP2000510164A (ja) 選択的神経ペプチドy受容体アンタゴニストとしてのアミド誘導体
CN102850324A (zh) 吲哚化合物
US20210340547A1 (en) Fibrotic treatment
ES2782357T3 (es) Inhibidores de IRE 1 alfa
ES2388196T3 (es) Derivados de 2-aril- y 2-heteroaril-4H-1-benzopiran-4-ona-6-amidino para el tratamiento de artritis, cáncer y dolor relacionado
CN103189357B (zh) 作为kcnq2/3调节剂的取代的2-氧代-和2-硫代-二氢喹啉-3-甲酰胺
EP3294721A1 (fr) Composés 4h-pyrane utilisés comme inhibiteurs de l'aminopeptidase régulée par l'insuline (irap)
CA2611072A1 (fr) Composes inedits et leurs utilisations
AU2007234577A1 (en) Novel compounds and uses thereof
US9828351B2 (en) Enzyme interacting agents
Li et al. Discovery of phenanthridine analogues as novel chemical probes disrupting the binding of DNA to ΔFosB homodimers and ΔFosB/JunD heterodimers
EP3801511A1 (fr) Dérivés de thiéno[2,3-b] pyridine en tant qu'inhibiteurs d'epac et leurs utilisations pharmaceutiques
AU2005282229B2 (en) Enzyme inhibitors and uses thereof
CN1148353C (zh) 一类磷脂酶甲2的抑制剂及其制备方法和用途
CN101679254A (zh) 用于炎症治疗的哌啶酮类
Asquith et al. Design and evaluation of novel 4-anilinoquinolines and quinazolines EGFR inhibitors in lung cancer and chordoma
CA2704250A1 (fr) Composes d'aryloxyamine et leur utilisation comme modulateurs des canaux sodiques

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20141119